AU3379597A - Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide - Google Patents

Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide

Info

Publication number
AU3379597A
AU3379597A AU33795/97A AU3379597A AU3379597A AU 3379597 A AU3379597 A AU 3379597A AU 33795/97 A AU33795/97 A AU 33795/97A AU 3379597 A AU3379597 A AU 3379597A AU 3379597 A AU3379597 A AU 3379597A
Authority
AU
Australia
Prior art keywords
modulation
chemical modifications
containing oligonucleotide
tetraplex
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33795/97A
Inventor
John Goodchild
Jia Liu Wolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aceragen Inc
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Publication of AU3379597A publication Critical patent/AU3379597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3515—Lipophilic moiety, e.g. cholesterol
AU33795/97A 1996-06-19 1997-06-09 Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide Abandoned AU3379597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2095496P 1996-06-19 1996-06-19
US60020954 1996-06-19
PCT/US1997/009842 WO1997048715A1 (en) 1996-06-19 1997-06-09 Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide

Publications (1)

Publication Number Publication Date
AU3379597A true AU3379597A (en) 1998-01-07

Family

ID=21801496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33795/97A Abandoned AU3379597A (en) 1996-06-19 1997-06-09 Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide

Country Status (2)

Country Link
AU (1) AU3379597A (en)
WO (1) WO1997048715A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912332A (en) * 1996-07-26 1999-06-15 Hybridon, Inc. Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
CN106535876B (en) 2014-06-04 2020-09-11 埃克西奎雷股份有限公司 Multivalent delivery of immunomodulators through liposomal spherical nucleic acids for prophylactic or therapeutic applications
CA2963931A1 (en) 2014-10-06 2016-04-14 Exicure, Inc. Anti-tnf compounds
JP2017537619A (en) 2014-11-21 2017-12-21 ノースウェスタン ユニバーシティ Sequence-specific intracellular uptake of spherical nucleic acid nanoparticle complexes
CN108064295A (en) * 2015-01-14 2018-05-22 埃克西奎雷股份有限公司 Nucleic acid nano structure with core motif
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011010A1 (en) * 1994-10-07 1996-04-18 Pharmagenics, Inc. Bridged and unbridged quadruplex/duplex oligonucleotides

Also Published As

Publication number Publication date
WO1997048715A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
AU4701796A (en) A supported catalytic activator
AU2093597A (en) Chemical compounds
AU7711298A (en) Hydrocarbon conversion process
AU7685198A (en) A controlled cleavage process
AU5317496A (en) Single-stranded circular oligonucleotides
AU5441896A (en) Cooperative oligonucleotides
AU6311698A (en) Immunopotentiators
AU5065996A (en) Downhole mixer
AUPM354694A0 (en) Chemical compounds
AU3379597A (en) Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide
AUPM725794A0 (en) Chemical compounds
AU3336795A (en) Fsk permutation modulation
AU1217797A (en) New compounds
AUPO132296A0 (en) Chemical process
AU7449696A (en) New organic gellation agents
AU7492996A (en) Catalytic burner
AU6939898A (en) Peroxynitrite decomposition catalyst
AUPN674795A0 (en) Undercutting drills
AUPO808297A0 (en) A process
AU6927998A (en) A water ride
AU4132493A (en) Chemical reaction
AU1515499A (en) A reactor
AUPM402094A0 (en) Chemical compounds
AU7368596A (en) Nucleic acid reactions
AUPO483897A0 (en) A toilet